Cargando…

Aurora-A Kinase as a Promising Therapeutic Target in Cancer

Mammalian Aurora family of serine/threonine kinases are master regulators of mitotic progression and are frequently overexpressed in human cancers. Among the three members of the Aurora kinase family (Aurora-A, -B, and -C), Aurora-A and Aurora-B are expressed at detectable levels in somatic cells un...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Assoro, Antonino B., Haddad, Tufia, Galanis, Evanthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701905/ https://www.ncbi.nlm.nih.gov/pubmed/26779440 http://dx.doi.org/10.3389/fonc.2015.00295

Ejemplares similares

Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells
por: Ohmine, Seiga, et al.
Publicado: (2018)

Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells
por: Opyrchal, Mateusz, et al.
Publicado: (2014)

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells
por: Opyrchal, Mateusz, et al.
Publicado: (2017)

Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells
por: LEONTOVICH, ALEXEY A., et al.
Publicado: (2013)

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
por: Jalalirad, Mohammad, et al.
Publicado: (2021)

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
por: Iankov, Ianko D., et al.
Publicado: (2015)

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
por: Hartsink-Segers, S A, et al.
Publicado: (2013)

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer
por: Haddad, Tufia C., et al.
Publicado: (2017)

Inhibition of Cdk2 kinase activity selectively targets the CD44(+)/CD24(−/Low) stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells
por: OPYRCHAL, MATEUSZ, et al.
Publicado: (2014)

Functions of Aurora kinase C in meiosis and cancer
por: Quartuccio, Suzanne M., et al.
Publicado: (2015)

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
por: Mancini, Manuela, et al.
Publicado: (2022)

Ubiquitin-Mediated Degradation of Aurora Kinases
por: Lindon, Catherine, et al.
Publicado: (2016)

Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma
por: Borah, Naheed Arfin, et al.
Publicado: (2021)

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
por: Ganapathi, Ram N., et al.
Publicado: (2020)

Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
por: Stefani, Alessio, et al.
Publicado: (2022)

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
por: Pidkovka, Nataliya, et al.
Publicado: (2023)

A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
por: de Groot, Christian O., et al.
Publicado: (2015)

Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases
por: Galetta, Domenico, et al.
Publicado: (2020)

Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
por: Guo, Zhenying, et al.
Publicado: (2021)

Functional Significance of Aurora Kinases–p53 Protein Family Interactions in Cancer
por: Sasai, Kaori, et al.
Publicado: (2016)

Roles of Notch Signaling in the Tumor Microenvironment
por: D’Assoro, Antonino B., et al.
Publicado: (2022)

The Dawn of Aurora Kinase Research: From Fly Genetics to the Clinic
por: Carmena, Mar, et al.
Publicado: (2015)

Skp2 is a Promising Therapeutic Target in Breast Cancer
por: Wang, Zhiwei, et al.
Publicado: (2012)

Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer
por: Nuñez-Olvera, Stephanie I., et al.
Publicado: (2019)

The Aurora B Kinase in Chromosome Bi-Orientation and Spindle Checkpoint Signaling
por: Krenn, Veronica, et al.
Publicado: (2015)

NOTCH3 expression is linked to breast cancer seeding and distant metastasis
por: Leontovich, Alexey A., et al.
Publicado: (2018)

Scientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer
por: Niu, Huifeng, et al.
Publicado: (2015)

CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023)

Phenotypic Screening Approaches to Develop Aurora Kinase Inhibitors: Drug Discovery Perspectives
por: Marugán, Carlos, et al.
Publicado: (2016)

PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
por: Remmerie, Michiel, et al.
Publicado: (2019)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

Aurora kinases: novel therapy targets in cancers
por: Tang, Anqun, et al.
Publicado: (2017)

Editorial: Aurora Kinases: Classical Mitotic Roles, Non-Canonical Functions and Translational Views
por: Pérez de Castro, Ignacio, et al.
Publicado: (2017)

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
por: Davis, S. Lindsey, et al.
Publicado: (2015)

Aurora kinase A in gastrointestinal cancers: time to target
por: Katsha, Ahmed, et al.
Publicado: (2015)

Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
por: Li, Yanfang, et al.
Publicado: (2013)

Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
por: Li, Ruyi, et al.
Publicado: (2021)

Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
por: Li, Yanfang, et al.
Publicado: (2018)

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
por: Dong, Peixin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r84rb96l0939i0q7qe2k36j1ac